Results 221 to 230 of about 35,670 (265)
Some of the next articles are maybe not open access.
Acta Clinica Belgica, 2014
Accurate detection of latent tuberculosis infection (LTBI) is becoming increasingly important due to the increasing use of immunosuppressive medications and the human immunodeficiency epidemic, which have increased the risk for reactivation to active tuberculosis (TB) infection.
E, De Keyser, F, De Keyser, F, De Baets
exaly +3 more sources
Accurate detection of latent tuberculosis infection (LTBI) is becoming increasingly important due to the increasing use of immunosuppressive medications and the human immunodeficiency epidemic, which have increased the risk for reactivation to active tuberculosis (TB) infection.
E, De Keyser, F, De Keyser, F, De Baets
exaly +3 more sources
Patch testing versus interferon‐gamma release assay in evaluation of drug eruptions
Fundamental & Clinical Pharmacology, 2021Abstract Delayed‐onset T‐cell‐mediated cutaneous adverse drug reactions are an uncommon but potentially serious result of medication exposures. Identification of culprit medications is crucial, but clinical diagnosis is often difficult.
Yehonatan Kaplan +3 more
openaire +2 more sources
Tuberculin skin test versus interferon-gamma release assays
Acta Clinica Belgica, 2014Dear Editor,We would like to discuss on the publication on ‘Tuberculin skin test versus interferon-gamma release assays.’1 De Keyser et al.
S S, Tin, V, Wiwanitkit
openaire +2 more sources
High reproducibility of the interferon-gamma release assay T-SPOT.TB in serial testing
European Journal of Clinical Microbiology & Infectious Diseases, 2020Longitudinal studies regarding the reproducibility of Interferon-gamma release assay (IGRA) T-SPOT.TB for the diagnosis of Mycobacterium tuberculosis (M. tb) infection in serial testing are limited. We retrospectively analysed results of serially tested subjects in a medical laboratory in Germany over a time period of 14 years.
Thomas Meier, Martin Enders
openaire +2 more sources
Absence of interferon-gamma release assay conversion following tuberculin skin testing
The International Journal of Tuberculosis and Lung Disease, 2011The tuberculin skin test (TST) has been the established screening method for tuberculosis (TB) for over a century. Interferon-gamma release assays (IGRAs) using Mycobacterium tuberculosis-specific antigens are increasingly used as diagnostic tests for TB.
Ritz, N. +5 more
openaire +3 more sources
Revista portuguesa de pneumologia, 2010
Healthcare workers (HCWs) have an increased risk of tuberculosis (TB). Screening for latent tuberculosis infection and active TB is therefore essential in infection control programs. Tuberculin skin test (TST) and Interferon -gamma Release Assay (IGRA) were used simultaneously in 1686 HCWs between May 2007 and April 2009.
José Torres, Costa +5 more
openaire +4 more sources
Healthcare workers (HCWs) have an increased risk of tuberculosis (TB). Screening for latent tuberculosis infection and active TB is therefore essential in infection control programs. Tuberculin skin test (TST) and Interferon -gamma Release Assay (IGRA) were used simultaneously in 1686 HCWs between May 2007 and April 2009.
José Torres, Costa +5 more
openaire +4 more sources
Pediatric Infectious Disease Journal, 2011
The interferon-gamma release assays have greater specificity than the tuberculin skin test (TST), and at least equal sensitivity. We analyzed the sensitivity and specificity of the TST in immunocompetent children considering QuantiFERON as the referent standard.
Ana, Méndez-Echevarría +5 more
openaire +2 more sources
The interferon-gamma release assays have greater specificity than the tuberculin skin test (TST), and at least equal sensitivity. We analyzed the sensitivity and specificity of the TST in immunocompetent children considering QuantiFERON as the referent standard.
Ana, Méndez-Echevarría +5 more
openaire +2 more sources